DK0916680T3 - Lantibiotikum beslægtet med actagardin, fremgangsmåde til fremstilling og anvendelse deraf - Google Patents

Lantibiotikum beslægtet med actagardin, fremgangsmåde til fremstilling og anvendelse deraf

Info

Publication number
DK0916680T3
DK0916680T3 DK98119105T DK98119105T DK0916680T3 DK 0916680 T3 DK0916680 T3 DK 0916680T3 DK 98119105 T DK98119105 T DK 98119105T DK 98119105 T DK98119105 T DK 98119105T DK 0916680 T3 DK0916680 T3 DK 0916680T3
Authority
DK
Denmark
Prior art keywords
actagardine
lantibiotic
akin
preparation
lantibiotic akin
Prior art date
Application number
DK98119105T
Other languages
English (en)
Inventor
Laszlo Dr Vertesy
Herbert Dr Kogler
Matthias Schiell
Joachim Dr Wink
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK0916680T3 publication Critical patent/DK0916680T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98119105T 1997-10-15 1998-10-09 Lantibiotikum beslægtet med actagardin, fremgangsmåde til fremstilling og anvendelse deraf DK0916680T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745583A DE19745583A1 (de) 1997-10-15 1997-10-15 Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben

Publications (1)

Publication Number Publication Date
DK0916680T3 true DK0916680T3 (da) 2004-05-24

Family

ID=7845627

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98119105T DK0916680T3 (da) 1997-10-15 1998-10-09 Lantibiotikum beslægtet med actagardin, fremgangsmåde til fremstilling og anvendelse deraf

Country Status (14)

Country Link
US (1) US6022851A (da)
EP (1) EP0916680B1 (da)
JP (1) JP3684432B2 (da)
KR (1) KR100482402B1 (da)
CN (1) CN1165547C (da)
AR (1) AR015962A1 (da)
AT (1) ATE258558T1 (da)
AU (1) AU739516C (da)
BR (1) BRPI9803914B1 (da)
CA (1) CA2250630C (da)
DE (2) DE19745583A1 (da)
DK (1) DK0916680T3 (da)
ES (1) ES2213862T3 (da)
PT (1) PT916680E (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861236B2 (en) * 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0600928D0 (en) * 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
EP1908774A1 (en) * 2006-10-06 2008-04-09 sanofi-aventis Antibacterial and antiviral peptides from Actinomadura namibiensis
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
AU2008364202A1 (en) * 2008-11-24 2011-07-07 Sentinella Pharmaceuticals, Inc. ("Sentinella") Lantibiotic carboxyamide derivatives with enhanced antibacterial activity
GB0900599D0 (en) * 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
DK2387580T3 (da) 2009-01-14 2014-10-13 Novacta Biosystems Ltd Deoxyactagardinderivater
EA020733B1 (ru) 2009-02-04 2015-01-30 Новакта Биосистемс Лимитед Производные актагардина
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
US20140094402A1 (en) * 2011-03-30 2014-04-03 Sentinella Pharmaceuticals, Inc. Lantibiotic NAI-802, Pharmaceutically Acceptable Salts, Compositions and Uses Thereof
DK3122764T3 (da) * 2014-03-25 2019-04-15 Lanthiopep Bv Cykliske apelin-analoger

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470407A (en) * 1974-07-27 1977-04-14 Lepetit Spa Antibiotic substances
GB8507528D0 (en) * 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions

Also Published As

Publication number Publication date
DE59810658D1 (de) 2004-03-04
KR19990037179A (ko) 1999-05-25
PT916680E (pt) 2004-06-30
CN1165547C (zh) 2004-09-08
DE19745583A1 (de) 1999-04-22
ATE258558T1 (de) 2004-02-15
CA2250630A1 (en) 1999-04-15
BR9803914A (pt) 2000-03-28
JP3684432B2 (ja) 2005-08-17
CN1221752A (zh) 1999-07-07
AR015962A1 (es) 2001-05-30
EP0916680A2 (de) 1999-05-19
EP0916680A3 (de) 2001-10-17
CA2250630C (en) 2008-07-15
HK1020739A1 (en) 2000-05-19
AU8926198A (en) 1999-05-06
AU739516C (en) 2002-05-02
JPH11193299A (ja) 1999-07-21
US6022851A (en) 2000-02-08
BRPI9803914B1 (pt) 2016-11-01
ES2213862T3 (es) 2004-09-01
EP0916680B1 (de) 2004-01-28
AU739516B2 (en) 2001-10-11
KR100482402B1 (ko) 2005-08-31

Similar Documents

Publication Publication Date Title
NO20006062L (no) Innkapslede brytere, blandinger og fremgangsmåte for anvendelse derav
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
IS4311A (is) Setin 1H-imíðazól, aðferð til framleiðslu þeirra og notkun þeirra
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
NO973048D0 (no) Elastiske sementsammensetninger og fremgangsmåter
PL318278A1 (en) Novel heteroaryl oxazolydinones, method of obtaining and drugs containing them
PL317929A1 (en) Pyrido-condenset thenyl- and furanyl oxazolydinones, method of obtaining and drugs containing them
DK0890359T3 (da) Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
DK0799052T3 (da) Ny antihrombotisk formulering, fremgangsmåde til dens fremstilling og anvendelse deraf
HUP0201783A2 (en) Anti-alfavbetha3 recombinant human antibodies, nucleic acids encoding same and methods
DK1114005T3 (da) Gipsholdigt produkt med foröget modstandsdygtighed over for permanent deformation og fremgangsmåde og sammensætning til fremstilling deraf
NO974528D0 (no) Sementeringsslurry og fremgangsmåte til utforming av formulering
DK0815922T3 (da) Fremgangsmåde til afsvovling og decarbonisering
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
GB2336969B (en) Method and apparatus for migrating embedded PBX system to personal computer
DK1047445T3 (da) Modificerede enzymer og anvendelse heraf til peptidsyntese
NO984517D0 (no) Nukleinsyre- og aminosyresekvenser relatert til Helicobacter pylori og vaksineblandinger derav
AU739516C (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
IS6151A (is) Örkorn óleysanleg í magavökva, aðferð til að aflaþeirra og lyfjaefnablöndur
NO984854L (no) FremgangsmÕte og anordning relatert til sendesekvensiering
DK0887562T3 (da) Dykker og fremgangsmåde til dens fremstilling
NO20023015D0 (no) Humant heparanasebeslektet polypeptid og nukleinsyre
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO973047L (no) Elastiske brönnsementsammensetninger og fremgangsmåter